Evidence map›Paper›PMID 29618576›Full record

ReviewClinical microbiology reviews2018

Options and Limitations in Clinical Investigation of Bacterial Biofilms.

Maria Magana, Christina Sereti, Anastasios Ioannidis, Courtney A Mitchell, Anthony R Ball, Emmanouil Magiorkinis, Stylianos Chatzipanagiotou, Michael R Hamblin, Maria Hadjifrangiskou, George P Tegos

Open access · bronzeAbstract readReview
In one paragraph

Review in Clinical microbiology reviews, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 109 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed, 2 pooled it
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

109 citing papers in PubMed, 2 syntheses or guidelines pooled it, 224 citations in OpenAlex.

  1. Key virulence genes associated withFrontiers in oral health · 2025
    Pooled it
  2. Microbial Biofilm Decontamination on Dental Implant Surfaces: A Mini Review.Frontiers in cellular and infection microbiology · 2021
    Pooled it
  3. Artificial intelligence catalyzes antimicrobial peptide design.Synthetic and systems biotechnology · 2027
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Journal of clinical microbiology · 2025
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Maria Magana *Department of Clinical Microbiology, Athens Medical School, Aeginition Hospital, Athens, Greece.
Christina Sereti *Department of Clinical Microbiology, Athens Medical School, Aeginition Hospital, Athens, Greece.
Anastasios IoannidisDepartment of Clinical Microbiology, Athens Medical School, Aeginition Hospital, Athens, Greece.
Courtney A MitchellDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee, USA.
Anthony R BallGliese 623b, Mendon, Massachusetts, USA.
Emmanouil MagiorkinisDepartment of Hygiene, Epidemiology and Medical Statistics, Medical School, University of Athens, Athens-Goudi, Greece.
Stylianos ChatzipanagiotouDepartment of Clinical Microbiology, Athens Medical School, Aeginition Hospital, Athens, Greece.
Michael R HamblinHarvard-MIT Division of Health Science and Technology, Cambridge, Massachusetts, USA.ORCID 0000-0001-6431-4605
Maria HadjifrangiskouDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
George P TegosGliese 623b, Mendon, Massachusetts, USA gtegos@gmail.com.
Eginition Hospital · GRHarvard University · USNational and Kapodistrian University of Athens · GRUniversity of Peloponnese · GRVanderbilt University · USVanderbilt University Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacteria can form single- and multispecies biofilms exhibiting diverse features based upon the microbial composition of their community and microenvironment. The study of bacterial biofilm development has received great interest in the past 20 years and is motivated by the elegant complexity characteristic of these multicellular communities and their role in infectious diseases. Biofilms can thrive on virtually any surface and can be beneficial or detrimental based upon the community's interplay and the surface. Advances in the understanding of structural and functional variations and the roles that biofilms play in disease and host-pathogen interactions have been addressed through comprehensive literature searches. In this review article, a synopsis of the methodological landscape of biofilm analysis is provided, including an evaluation of the current trends in methodological research. We deem this worthwhile because a keyword-oriented bibliographical search reveals that less than 5% of the biofilm literature is devoted to methodology. In this report, we (i) summarize current methodologies for biofilm characterization, monitoring, and quantification; (ii) discuss advances in the discovery of effective imaging and sensing tools and modalities; (iii) provide an overview of tailored animal models that assess features of biofilm infections; and (iv) make recommendations defining the most appropriate methodological tools for clinical settings.

Indexed as

Bacterial Physiological PhenomenaBiofilmsAnimalsHumansMicrobiological TechniquesModels, Animalanimal host modelsbiofilmsflow cellsimagingquantification

Identifiers

PMID29618576
PMCPMC6056845
OpenAlexW2796114057

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.